Cargando…

Drug repositioning prediction for psoriasis using the adverse event reporting database

INTRODUCTION: Inverse signals produced from disproportional analyses using spontaneous drug adverse event reports can be used for drug repositioning purposes. The purpose of this study is to predict drug candidates using a computational method that integrates reported drug adverse event data, diseas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ko, Minoh, Oh, Jung Mi, Kim, In-Wha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076533/ https://www.ncbi.nlm.nih.gov/pubmed/37035327 http://dx.doi.org/10.3389/fmed.2023.1159453

Ejemplares similares

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
por: Han, Nayoung, et al.
Publicado: (2021)

Screening of Drug Repositioning Candidates for Castration Resistant Prostate Cancer
por: Kim, In-Wha, et al.
Publicado: (2019)

Meta-analysis of the impact of thioprine S-methyltransferase polymorphisms on the tolerable 6-mercaptopurine dose considering initial dose and ethnic difference
por: Kim, Myeong Gyu, et al.
Publicado: (2016)

Assessment of adverse events related to anti-influenza neuraminidase inhibitors using the FDA adverse event reporting system and online patient reviews
por: Han, Nayoung, et al.
Publicado: (2020)

The Immunogenetics of Psoriasis and Implications for Drug Repositioning
por: Xu, Xuan, et al.
Publicado: (2017)

Lung Cancer Adverse Events Reports for Angiotensin-Converting Enzyme Inhibitors: Data Mining of the FDA Adverse Event Reporting System Database
por: Meng, Long, et al.
Publicado: (2021)

RETRACTED ARTICLE: Computational Drug Repositioning for Gastric Cancer using Reversal Gene Expression Profiles
por: Kim, In-Wha, et al.
Publicado: (2019)

Retraction Note: Computational Drug Repositioning for Gastric Cancer using Reversal Gene Expression Profiles
por: Kim, In-Wha, et al.
Publicado: (2022)

A standard database for drug repositioning
por: Brown, Adam S., et al.
Publicado: (2017)

Analysis of anticholinergic adverse effects using two large databases: The US Food and Drug Administration Adverse Event Reporting System database and the Japanese Adverse Drug Event Report database
por: Nagai, Junko, et al.
Publicado: (2021)

Data mining techniques for detecting signals of adverse drug reaction of cardiac therapy drugs based on Jinan adverse event reporting system database: a retrospective study
por: Guan, Yuyao, et al.
Publicado: (2023)

Clinical impacts of the concomitant use of L-asparaginase and total parenteral nutrition containing L-aspartic acid in patients with acute lymphoblastic leukemia
por: Ko, Minoh, et al.
Publicado: (2023)

Categorisation of Pharmaceutical Adverse Events Using the Japanese Adverse Drug Event Report Database: Characteristic Adverse Drug Events of the Elderly Treated with Polypharmacy
por: Negishi, Akio, et al.
Publicado: (2020)

Systematic drug repositioning through mining adverse event data in ClinicalTrials.gov
por: Su, Eric Wen, et al.
Publicado: (2017)

Characteristics of pediatric adverse drug reaction reports in the Japanese Adverse Drug Event Report Database
por: Noda, Aoi, et al.
Publicado: (2020)

In Silico Approach to Predict Severe Cutaneous Adverse Reactions Using the Japanese Adverse Drug Event Report Database
por: Ambe, Kaori, et al.
Publicado: (2021)

Visualization of Kinase Inhibition-Related Adverse Events Using the Japanese Adverse Drug Event Report Database
por: Mizuno, Takahito, et al.
Publicado: (2021)

Characteristics of Adverse Events Following Immunization Reporting in Children: The Japanese Adverse Drug Event Report Database
por: Noda, Aoi, et al.
Publicado: (2020)

Drug repositioning of polaprezinc for bone fracture healing
por: Ko, Eun Ae, et al.
Publicado: (2022)

Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database
por: Yamashiro, Kaito, et al.
Publicado: (2022)

Opportunities for Web-based Drug Repositioning: Searching for Potential Antihypertensive Agents with Hypotension Adverse Events
por: Wang, Kejian, et al.
Publicado: (2016)

A computational multi-targeting approach for drug repositioning for psoriasis treatment
por: Ibezim, Akachukwu, et al.
Publicado: (2021)

Integrative transcriptome-wide analysis of atopic dermatitis for drug repositioning
por: Song, Jaeseung, et al.
Publicado: (2022)

Psoriasis adverse events and associated medications as reported in the US Food and Drug Administration’s Adverse Event Reporting System from 2016 to 2021
por: Learned, Christine, et al.
Publicado: (2022)

Assessment and monitoring of biologic drug adverse events in patients with psoriasis
por: Hanley, Tessa, et al.
Publicado: (2016)

Signal Detection of Adverse Drug Reaction of Amoxicillin Using the Korea Adverse Event Reporting System Database
por: Soukavong, Mick, et al.
Publicado: (2016)

PROMISCUOUS: a database for network-based drug-repositioning
por: von Eichborn, Joachim, et al.
Publicado: (2011)

Adverse Skin Reactions with Antiepileptic Drugs Using Korea Adverse Event Reporting System Database, 2008–2017
por: Kim, Hyun Kyung, et al.
Publicado: (2019)

Database of adverse events associated with drugs and drug combinations
por: Poleksic, Aleksandar, et al.
Publicado: (2019)

Hepatotoxicity-Related Adverse Effects of Proton Pump Inhibitors: A Cross-Sectional Study of Signal Mining and Analysis of the FDA Adverse Event Report System Database
por: Zeng, Yifan, et al.
Publicado: (2021)

Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database
por: Sonawane, Kalyani B., et al.
Publicado: (2018)

Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database
por: Hasegawa, Shiori, et al.
Publicado: (2017)

Adverse reaction profiles of hemorrhagic adverse reactions caused by direct oral anticoagulants analyzed using the Food and Drug Administration Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER) database
por: Shimada, Kazuyo, et al.
Publicado: (2019)

Reporting of adverse events for marketed drugs: Need for strengthening safety database
por: Apte, Aditi Anand
Publicado: (2016)

Ceritinib‐associated hyperglycemia in the Japanese Adverse Drug Event Report Database
por: Fujita, Haruka, et al.
Publicado: (2019)

Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning
por: Kim, Yoonbee, et al.
Publicado: (2022)

Pathway Analysis for Drug Repositioning Based on Public Database Mining
por: Pan, Yongmei, et al.
Publicado: (2014)

Drug-Repositioning Approaches Based on Medical and Life Science Databases
por: Zamami, Yoshito, et al.
Publicado: (2021)

Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database
por: Toki, Tadashi, et al.
Publicado: (2018)

Analysis of adverse events of renal impairment related to platinum-based compounds using the Japanese Adverse Drug Event Report database
por: Naganuma, Misa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_etf69krfgh93odqoilngbo5r16